Recent Company News

• 03:03 AM ET Apr 24, 2025
  

  Ajinomoto guides FY net income attributable ¥74.90B vs prior guidance ¥95.00B and FactSet ¥100.75B [11 est, ¥95-115.30B] (¥2883.0000, 0)

• 08:38 PM ET Apr 03, 2025
  

  Citi initiates 2801.JP, 2802.JP (pre-Japan open)

• 11:26 PM ET Mar 27, 2025
  

  StreetAccount Summary: Asian stocks reaching new 52-week highs/lows (59 total)

• 08:11 AM ET Feb 13, 2025
  

  Bio-Path Holdings provides updates on Phase 1/1B BP1001-A trial and also Phase 2 triple combination study of prexigebersen in AML ($0.72, 0.00)

• 11:31 PM ET Feb 09, 2025
  

  AI emerges as stronger than expected tailwind for Japan manufacturer earnings:

• 01:55 AM ET Feb 03, 2025
  

  StreetAccount Metrics Recap - Ajinomoto Q3 Earnings (¥6226.0000, 0)

• 01:54 AM ET Feb 03, 2025
  

  Ajinomoto reports Q3 net income attributable ¥32.2B vs StreetAccount ¥32.20B (¥6226.0000, 0)

• 01:49 AM ET Feb 03, 2025
  

  Ajinomoto president, CEO Taro Fujie to be appointed as chairman, effective 3-Feb (¥6226.0000, 0)

• 09:16 PM ET Jan 30, 2025
  

  StreetAccount Consensus Metrics Preview - Ajinomoto Q3 Earnings (¥6260.0000, -10)

• 01:36 AM ET Jan 29, 2025
  

  Ajinomoto completes previously announced share buyback (¥6229.0000, 0)